{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:15:18Z","timestamp":1787606118987,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Hospitals Authority Youth Program","award":["QML20232001"],"award-info":[{"award-number":["QML20232001"]}]},{"DOI":"10.13039\/501100005089","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7212054"],"award-info":[{"award-number":["7212054"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2024-1-4111"],"award-info":[{"award-number":["2024-1-4111"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81771452"],"award-info":[{"award-number":["No. 81771452"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-37396-z","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:05:54Z","timestamp":1769767554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Decreased N-acetylaspartate plus N-acetyl-aspartyl-glutamate levels in the caudate of schizophrenia patients with tardive dyskinesia"],"prefix":"10.1038","volume":"16","author":[{"given":"Ting","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhuang","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fude","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baopeng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingguang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"2","key":"37396_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/02698811211055812","volume":"36","author":"G Rekhi","year":"2022","unstructured":"Rekhi, G., Tay, J. & Lee, J. Impact of drug-induced parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia. J. Psychopharmacol. 36 (2), 183\u2013190 (2022).","journal-title":"J. Psychopharmacol."},{"key":"37396_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.euroneuro.2020.07.003","volume":"38","author":"S Walther","year":"2020","unstructured":"Walther, S. et al. Movement disorder and sensorimotor abnormalities in schizophrenia and other psychoses - European consensus on assessment and perspectives. Eur. Neuropsychopharmacol. 38, 25\u201339 (2020).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"37396_CR3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neubiorev.2021.11.027","volume":"132","author":"LE Pieters","year":"2022","unstructured":"Pieters, L. E., Nadesalingam, N., Walther, S. & van Harten P. N. A systematic review of the prognostic value of motor abnormalities on clinical outcome in psychosis. Neurosci. Biobehav Rev. 132, 691\u2013705 (2022).","journal-title":"Neurosci. Biobehav Rev."},{"issue":"6","key":"37396_CR4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/FBP.0000000000000563","volume":"31","author":"AM Szota","year":"2020","unstructured":"Szota, A. M. & Scheel-Kr\u00fcger, J. The role of glutamate receptors and their interactions with dopamine and other neurotransmitters in the development of tardive dyskinesia: preclinical and clinical results. Behav. Pharmacol. 31 (6), 511\u2013523 (2020).","journal-title":"Behav. Pharmacol."},{"issue":"4","key":"37396_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/oxfordjournals.schbul.a033415","volume":"25","author":"PN van Harten","year":"1999","unstructured":"van Harten, P. N. & Kahn, R. S. Tardive dystonia. Schizophr Bull. 25 (4), 741\u2013748 (1999).","journal-title":"Schizophr Bull."},{"key":"37396_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0306-4522(01)00455-9","volume":"109","author":"IJ Mitchell","year":"2002","unstructured":"Mitchell, I. J., Cooper, A. C., Griffiths, M. R. & Cooper, A. J. Acute administration of haloperidol induces apoptosis of neurones in the striatum and substantia Nigra in the rat. Neuroscience 109, 89\u201399 (2002).","journal-title":"Neuroscience"},{"key":"37396_CR7","doi-asserted-by":"publisher","first-page":"110370","DOI":"10.1016\/j.pnpbp.2021.110370","volume":"111","author":"D Hirjak","year":"2021","unstructured":"Hirjak, D. et al. Progress in sensorimotor neuroscience of schizophrenia spectrum disorders: lessons learned and future directions. Prog Neuropsychopharmacol. Biol. Psychiatry. 111, 110370 (2021).","journal-title":"Prog Neuropsychopharmacol. Biol. Psychiatry"},{"key":"37396_CR8","doi-asserted-by":"publisher","first-page":"135548","DOI":"10.1016\/j.neulet.2020.135548","volume":"742","author":"T Yu","year":"2021","unstructured":"Yu, T. et al. Abnormal functional connectivity of motor circuit in the schizophrenic patients with tardive dyskinesia: A resting-state fMRI study. Neurosci. Lett. 742, 135548 (2021).","journal-title":"Neurosci. Lett."},{"key":"37396_CR9","doi-asserted-by":"publisher","first-page":"111724","DOI":"10.1016\/j.pscychresns.2023.111724","volume":"335","author":"T Yu","year":"2023","unstructured":"Yu, T. et al. Regional homogeneity in schizophrenia patients with tardive dyskinesia: a resting-state fMRI study. Psychiatry Res. Neuroimaging. 335, 111724 (2023).","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"37396_CR10","doi-asserted-by":"publisher","first-page":"12884","DOI":"10.1038\/s41598-018-31186-y","volume":"8","author":"T Yu","year":"2018","unstructured":"Yu, T. et al. Decreased Gray matter volume of cuneus and lingual gyrus in schizophrenia patients with tardive dyskinesia is associated with abnormal involuntary movement. Sci. Rep. 8, 12884 (2018).","journal-title":"Sci. Rep."},{"issue":"1","key":"37396_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1192\/bjp.bp.112.114538","volume":"203","author":"S Sarr\u00f3","year":"2013","unstructured":"Sarr\u00f3, S. et al. Structural brain changes associated with tardive dyskinesia in schizophrenia. Br. J. Psychiatry. 203 (1), 51\u201357 (2013).","journal-title":"Br. J. Psychiatry"},{"key":"37396_CR12","doi-asserted-by":"crossref","unstructured":"Mion, C. C., Andreasen, N. C., Arndt, S., Swayze, V. W. 2, Cohen, G. A. & nd, MRI abnormalities in tardive dyskinesia. Psychiatry Res. 40, 157\u2013166 (1991).","DOI":"10.1016\/0925-4927(91)90007-D"},{"issue":"12","key":"37396_CR13","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/0006-3223(90)90603-Y","volume":"28","author":"G Bartzokis","year":"1990","unstructured":"Bartzokis, G., Garber, H. J., Marder, S. R. & Olendorf, W. H. MRI in tardive dyskinesia: shortened left caudate T2. Biol. Psychiatry. 28 (12), 1027\u20131036 (1990).","journal-title":"Biol. Psychiatry"},{"key":"37396_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jpsychires.2021.08.010","volume":"142","author":"N Li","year":"2021","unstructured":"Li, N. et al. N-methyl-D-aspartate receptor antibody and the choroid plexus in schizophrenia patients with tardive dyskinesia. J. Psychiatr Res. 142, 290\u2013298 (2021).","journal-title":"J. Psychiatr Res."},{"key":"37396_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuroscience.2018.06.014","volume":"385","author":"P Zhang","year":"2018","unstructured":"Zhang, P. et al. Resting-state brain activity changes associated with tardive dyskinesia in patients with schizophrenia: fractional amplitude of Low-frequency fluctuation decreased in the occipital lobe. Neuroscience 385, 237\u2013245 (2018).","journal-title":"Neuroscience"},{"issue":"2\u20133","key":"37396_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0920-9964(01)00290-0","volume":"57","author":"K Ando","year":"2002","unstructured":"Ando, K. et al. Neural damage in the lenticular nucleus linked with tardive dyskinesia in schizophrenia: a preliminary study using proton magnetic resonance spectroscopy. Schizophr Res. 57 (2\u20133), 273\u2013279 (2002).","journal-title":"Schizophr Res."},{"issue":"7","key":"37396_CR17","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/mds.21459","volume":"22","author":"Y Kuznetsov","year":"2007","unstructured":"Kuznetsov, Y., Khiat, A., Blanchet, P. J. & Boulanger, Y. Proton magnetic resonance spectroscopy study of dyskinesia patients. Mov. Disord. 22 (7), 957\u2013962 (2007).","journal-title":"Mov. Disord"},{"key":"37396_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.parkreldis.2017.07.028","volume":"43","author":"G Barbagallo","year":"2017","unstructured":"Barbagallo, G. et al. Thalamic neurometabolic alterations in tremulous parkinson\u2019s disease: A preliminary proton MR spectroscopy study. Parkinsonism Relat. Disord. 43, 78\u201384 (2017).","journal-title":"Parkinsonism Relat. Disord"},{"key":"37396_CR19","doi-asserted-by":"publisher","first-page":"106574","DOI":"10.1016\/j.nbd.2024.106574","volume":"199","author":"Y Jing","year":"2024","unstructured":"Jing, Y., Dogan, I., Reetz, K. & Romanzetti, S. Neurochemical changes in the progression of huntington\u2019s disease: A meta-analysis of in vivo(1)H-MRS studies. Neurobiol. Dis. 199, 106574 (2024).","journal-title":"Neurobiol. Dis."},{"key":"37396_CR20","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/mds.26181","volume":"30","author":"IM Adanyeguh","year":"2015","unstructured":"Adanyeguh, I. M. et al. In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7. Mov. Disord. 30, 662\u2013670 (2015).","journal-title":"Mov. Disord"},{"key":"37396_CR21","doi-asserted-by":"publisher","first-page":"137224","DOI":"10.1016\/j.neulet.2023.137224","volume":"805","author":"M Yuan","year":"2023","unstructured":"Yuan, M., Du, N. & Song, Z. Primary motor area-related injury of anterior central gyrus in parkinson\u2019s disease with dyskinesia: A study based on MRS and Q-space. Neurosci. Lett. 805, 137224 (2023).","journal-title":"Neurosci. Lett."},{"key":"37396_CR22","doi-asserted-by":"crossref","unstructured":"\u00d6z, G. et al. Advanced single voxel (1) H magnetic resonance spectroscopy techniques in humans: Experts\u2019 consensus recommendations.\u00a0e4236\u00a0(NMR Biomed, 2020).","DOI":"10.1002\/nbm.4236"},{"key":"37396_CR23","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1001\/archpsyc.1982.04290040080014","volume":"39","author":"NR Schooler","year":"1982","unstructured":"Schooler, N. R. & Kane, J. M. Research diagnoses for tardive dyskinesia. Arch. Gen. Psychiatry. 39, 486\u2013487 (1982).","journal-title":"Arch. Gen. Psychiatry"},{"key":"37396_CR24","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/mds.27769","volume":"34","author":"M Stacy","year":"2019","unstructured":"Stacy, M. et al. Abnormal involuntary movement scale in tardive dyskinesia: minimal clinically important difference. Mov. Disord. 34, 1203\u20131209 (2019).","journal-title":"Mov. Disord"},{"key":"37396_CR25","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1212\/WNL.0b013e3181fc27e4","volume":"75","author":"A Sturrock","year":"2010","unstructured":"Sturrock, A. et al. Magnetic resonance spectroscopy biomarkers in premanifest and early huntington disease. Neurology 75, 1702\u20131710 (2010).","journal-title":"Neurology"},{"key":"37396_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3233\/JHD-140117","volume":"3","author":"SJ van den Bogaard","year":"2014","unstructured":"van den Bogaard, S. J. et al. Longitudinal metabolite changes in huntington\u2019s disease during disease onset. J. Huntington\u2019s Disease. 3, 377\u2013386 (2014).","journal-title":"J. Huntington\u2019s Disease"},{"key":"37396_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12311-020-01201-y","volume":"20","author":"AS Grosch","year":"2021","unstructured":"Grosch, A. S. et al. Neurochemical differences in spinocerebellar ataxia type 14 and 1. Cerebellum 20, 169\u2013178 (2021).","journal-title":"Cerebellum"},{"key":"37396_CR28","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/mds.23067","volume":"25","author":"G Oz","year":"2010","unstructured":"Oz, G. et al. Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status. Mov. Disord. 25, 1253\u20131261 (2010).","journal-title":"Mov. Disord"},{"key":"37396_CR29","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/mds.25107","volume":"27","author":"JT Teo","year":"2012","unstructured":"Teo, J. T., Edwards, M. J. & Bhatia, K. Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis. Mov. Disord. 27, 1205\u20131215 (2012).","journal-title":"Mov. Disord"},{"key":"37396_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.schres.2024.04.017","volume":"269","author":"N Li","year":"2024","unstructured":"Li, N. et al. Immunosenescence-related T cell phenotypes and white matter in schizophrenia patients with tardive dyskinesia. Schizophr Res. 269, 36\u201347 (2024).","journal-title":"Schizophr Res."},{"key":"37396_CR31","doi-asserted-by":"publisher","first-page":"e0162583","DOI":"10.1371\/journal.pone.0162583","volume":"11","author":"D Obert","year":"2016","unstructured":"Obert, D. et al. Brain metabolite changes in patients with Relapsing-Remitting and secondary progressive multiple sclerosis: A Two-Year Follow-Up study. PLoS ONE. 11, e0162583 (2016).","journal-title":"PLoS ONE"},{"issue":"2","key":"37396_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.bbr.2012.03.045","volume":"231","author":"SE Bachus","year":"2012","unstructured":"Bachus, S. E., Yang, E., McCloskey, S. S. & Minton, J. N. Parallels between behavioral and neurochemical variability in the rat vacuous chewing movement model of tardive dyskinesia. Behav. Brain Res. 231 (2), 323\u2013336 (2012).","journal-title":"Behav. Brain Res."},{"issue":"6","key":"37396_CR33","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1001\/archpsyc.1987.01800180032006","volume":"44","author":"GK Thaker","year":"1987","unstructured":"Thaker, G. K. et al. Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment. Arch. Gen. Psychiatry. 44 (6), 522\u2013529 (1987).","journal-title":"Arch. Gen. Psychiatry"},{"issue":"10","key":"37396_CR34","doi-asserted-by":"publisher","first-page":"101208","DOI":"10.1016\/j.xcrm.2023.101208","volume":"4","author":"Y Abe","year":"2023","unstructured":"Abe, Y. et al. Shared GABA transmission pathology in dopamine agonist- and antagonist-induced dyskinesia. Cell. Rep. Med. 4 (10), 101208 (2023).","journal-title":"Cell. Rep. Med."},{"issue":"20","key":"37396_CR35","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1007\/s00213-017-4695-5","volume":"234","author":"Y Oda","year":"2017","unstructured":"Oda, Y. et al. Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model rats. Psychopharmacol. (Berl). 234 (20), 3027\u20133036 (2017).","journal-title":"Psychopharmacol. (Berl)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37396-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37396-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37396-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T09:36:09Z","timestamp":1771320969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37396-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37396"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37396-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6773"}}